Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Pharmacology|April 5, 2018
Drug Repositioning in Glioblastoma: A Pathway PerspectiveSze Kiat Tan, Anna Jermakowicz, Adnan K Mookhtiar, et al.
Frontiers in Pharmacology|November 9, 2018
Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of TargetsUzma Saqib, Tanya T Kelley, Siva K Panguluri, et al.
Neuropharmacology|August 26, 2015
Noribogaine is a G-protein biased κ-opioid receptor agonistEmeline L Maillet, Nicolas Milon, Mari D Heghinian, et al.
ACS Omega|September 9, 2017
Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding SimulationsBryce K Allen, Saurabh Mehta, Stuart W J Ember, et al.
ACS Chemical Biology|September 14, 2012
Novel selective allosteric and bitopic ligands for the S1P(3) receptorEuijung Jo, Barun Bhhatarai, Emanuela Repetto, et al.
Journal of Computer-Aided Molecular Design|September 10, 2011
Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotypeDušica Vidović, Yuli Xie, Alison Rinderspacher, et al.
Plos One|November 17, 2012
Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO)Uma D Vempati, Magdalena J Przydzial, Caty Chung, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual InhibitorsSana Chaudhry, Jesus R Castro, Tulasigeri M Totiger, et al.
Pageof 10